throbber
A LABORATORY MANUAL
`
`T. Maniatis
`E. F. Fritsch
`J. Sambrook
`
`Harvard University
`
`Michigan State university
`
`Cold spring Harbor Laboratory
`
`y
`
`CSH
`
`cold Spring Harbor Laboratory
`
`Mylan v. Genentech
`IPR2016-00710
`Merck Ex. 1095, Pg. 1
`
`

`

`Molecular
`Cloning
`A LABORATORY MANUAL
`
`All rights reserved
`© 1982 by Cold Spring Harbor Laboratory
`Printed in the United States of America
`Book and cover design by Emily Harste
`
`Front cover: The electron micrograph of
`bacteriophage k particles stained with uranyl
`acetate was digitized and assigned false color
`by computer. Thomas R. Broker, Louise T.
`Chow, and James I. Garrets
`Back cover: E. coli VL361 with fimbriae was
`negatively stained with phosphotungstic acid
`and the electron micrograph was digitized and
`assigned false color by computer. Jeffrey A.
`Engler, Thomas R. Broker, and James L
`Garrets
`
`Cataloging in Publications data
`Maniatis, T.
`Molecular cloning.
`(A laboratory manual)
`Bibliography: p.
`Includes index.
`1. Molecular cloning.
`2. Eukaryotic
`cells.
`I. Fritsch, Edward F.
`II. Sambrook,
`Joseph.
`III. Title.
`IV. Series.
`QH442.2.F74
`574.87'3224
`ISBN 0-87969-136-0
`
`81-68891
`AACR2
`
`i
`
`2
`
`■-
`
`■ .■*
`/J-
`
`£.
`
`Users of this manual are cautioned against proceeding" without regard for prudent laboratory
`safety procedures. Cold Spring Harbor Laboratory makes no representations or warranties
`with respect to the material set forth in this manual and will not be liable for any damages
`or
`injury that might result from the use of the procedures set forth herein.
`
`Other manuals available from Cold Spring Harbor Laboratory
`Hybridoma Techniques
`Experiments with Normal and Transformed Cells
`Advanced Bacterial Genetics,
`Experiments in Molecular Genetics
`A Manual for Genetic Engineering
`(Strain Kit available)
`(Strain Kit available)
`Methods in Ye^t Genetics
`
`All Cold Spring Harbor Laboratory publications are available through booksellers or may be ordered
`directly from Cold Spring Harbor Laboratory, Box 100, Cold Spring Harbor, New York.
`SAN 203-6185
`
`Merck Ex. 1095, Pg. 2
`
`

`

`•A'
`
`^72"w}
`
`This manual began as a collection of laboratory protocols that were used
`during the 1980 Cold Spring Harbor course on the Molecular Cloning of
`Eukaryotic Genes. These procedures had been in use in our laboratories at
`that time but were scattered throughout the notebooks of many different
`people. In 1981 we decided to produce a more complete and up-to-date man­
`ual not only for use in the next Cold Spring Harbor course, but also for
`eventual publication. Out of the many permutations of the methods being
`used, we assembled a set of "
`,
`consensus protocols,” which were photocopied
`and widely distributed to many laboratories even as the 1981 course was
`underway. Then in the winter of 1981-1982, the manual was substantially
`rewritten, and new or revised protocols and figures, as well as entirely new
`chapters, were added.
`Even since this last rewriting, however, the field has progressed: New
`methods are constantly being invented and existing techniques are altered in
`response to changing needs. Although we have included in this manual only
`those protocols that have been thoroughly tested and used successfully in oiir
`laboratories, we make no claim that they are inviolable or perfect. We would
`welcome suggestions for improvements, and we would be grateful to be told
`about any new procedures that are devised.
`The evolution of protocols poses the difficult problem of attribution. We
`have tried to give credit at appropriate places in the text to the people who
`originally developed the procedures presented here, but in many cases trac­
`ing a particular method to its undisputed roots has proved to be impossible.
`We therefore wish to apologize—and to express gratitude—to those we have
`been unable to acknowledge for an idea, procedure, or recipe. Our major
`function has been to compile, to verify, and, we hope, to clarify; less fre­
`quently we have introduced modifications, and only in rare instances have
`we devised new protocols. In large part, then, the manual is based on proce­
`dures developed by others, and it is to them that any credit belongs.
`Because the manual was originally written to serve as a guide to those who
`had little experience in molecular cloning, it contains much basic material.
`However, the current version also deals in detail with almost every labora­
`tory task currently used in molecular cloning. We therefore hope that new­
`comers to cloning and veterans alike will find material of value in this book.
`Although molecular cloning seems straightforward on paper, it is more
`difficult to put into practice. Most protocols involve a large number of indi­
`vidual steps and a problem with any one of them can lead the experimenter
`into difficulty. To deal with these problems, a well-founded understanding of
`the principles underlying each procedure is essential. We have therefore
`provided background information and references that may be useful if trou-
`
`ii
`
`1
`
`Merck Ex. 1095, Pg. 3
`
`

`

`iv PREFACE
`
`bie should arise. We also suggest that, as a matter of course, the products of
`each step in a protocol be tested to verify that the reaction was successful.
`This manual could not have been written without the help and advice of
`members of our laboratories and contributions from many others. We there­
`fore wish to thank John Fiddes, Mary-Jane Gething, David Goldberg, Steve
`Hughes, David Ish-Horowicz, Mike Mathews, Patty Reichel, Joe Sorge, Jim
`Stringer, Richard Treisman, and Nigel Whittle. We wish particularly to
`thank Arg Efstratiadis for his helpful discussions and criticisms of Chapter
`7; Brian Seed for permission to include a description of his unpublished
`procedure for screening libraries by recombination (Chapter 10) and many
`other useful suggestions; Doug Hanahan for advice on transformation (Chap­
`ter 8); Bryan Roberts for suggestions on methods of hybrid-selection and
`cDNA cloning; Doug Melton for providing a protocol for injection of Xenopus
`ooc3Ttes; Ronni Greene for suggesting improvements to many protocols; Nina
`Irwin for providing a critical anthology of methods available for expressing
`eukaryotic proteins in bacteria (Chapter 12); Rich Roberts for supplying the
`computer analysis of the sequence of pBR322; Barbara Bachmann for
`reviewing and correcting the list of E. coli strains; and Tom Broker, Louise
`Chow, Jeff Engler, and Jim Garrels for producing the elegant photographs
`used.for the front and back covers.
`We also thank all those who participated in the Cold Spring Harbor Molec­
`ular Cloning courses of 1980 and 1981. They were an excellent group of
`students, who struggled through the first two drafts of the manual and made
`many useful suggestions. We also thank Nancy Hopkins, who helped us to
`teach the course the first year and convinced us that producing a manual
`would be a worthwhile task. In 1981 Doug Engel helped teach the course and
`suggested many improvements to the manual. Contributing to the success ofy"
`both courses were the efforts of the teaching assistants, who were Catherine*^^
`O’Connell and Helen Doris Keller in the summer of 1980 and Susan Vande^
`Woude, Paul Bates, and Michael Weiss in 1981.
`We wish to thank Patti Barkley and Marilyn Goodwin for their cheerful­
`ness and forbearance during the typing of successive revisions of the manu­
`script. Our artists, Fran Cefalu and Mike Ockler, worked with great
`dedication and perseverance to produce the drawings for the manual. Joan
`Ebert kept track of the many references added to and deleted from the text
`and assembled the reference list. We are also grateful to Nancy Ford, Direc­
`tor of Publications, Cold Spring Harbor Laboratory, for her encouragement
`and support. Finally, without the patience, skill, and diplomacy of Doug
`Owen, who prepared the manuscript for the printer and helped us in many
`other ways, this book would not exist.
`
`Tom Maniatis
`Ed Fritsch
`Joe Sambrook
`
`-f;
`
`Merck Ex. 1095, Pg. 4
`
`

`

`contents
`
`Preface, v .
`
`1 Vector-Host Systems
`Plasmids, 3
`Cloning in Plasmids, 11
`Bacteriophage x, 17
`The Lytic Cycle, 17
`Lysogeny, 22
`Construction of Bacteriophage k Vectors, 22
`Choosing the Appropriate Vector, 24
`Maps of Bacteriophage k Vectors, 25
`Cosmids, 45
`.
`Single-stranded Bacteriophages, 51
`Summary, 52
`
`V
`
`/
`
`2 Propagation and Maintenance of Bacterial Strains
`and Viruses
`strain Verification, 57
`Isolation of Single Colonies, 58
`Growth, Maintenance, and Preservation of Bacterial Strains, 61
`Plaque Purification of Bacteriophage k. 63
`Preparing Stocks of Bacteriophage k from Single Plaques, 65
`Media and Antibiotics, 68
`Liquid Media, 68
`Media Containing Agar or Agarose, 70
`Antibiotics, 71
`
`.
`
`V
`
`3 Isolation of Bacteriophage x and Plasmid DIMA
`Large-scale Preparation of Bacteriophage k, 76
`Infection, 77
`Induction, 78
`Purification of Bacteriophage k, 80
`Extraction of Bacteriophage k DNA, 85
`Large-scale isolation of Plasmid DNA, 86
`Growth of Bacteria and Amplification-of the Plasmid, 88
`
`'
`
`1
`
`55
`
`75
`
`V
`
`y.
`
`P:
`
`.y
`
`'i
`
`;V
`
`r'f
`
`>1
`
`i
`
`t
`
`\4
`
`\
`
`y
`
`54 .
`
`if
`
`•3
`
`x,’
`i
`
`Merck Ex. 1095, Pg. 5
`
`

`

`Vi CONTENTS
`
`Harvesting and Lysis of Bacteria, 89
`Purification of Closed Circular DNA by Centrifugation to Equilibrium in Cesium
`Chloride-Ethidium Bromide Gradients, 93
`Removal of RNA from Preparations of Plasmid DNA, 95
`
`97
`
`/
`
`149
`
`4 Enzymes used in Molecular Cloning
`Restriction Enzymes. 98
`Isoschizomers, 99
`Methylation, 102
`Digesting DNA with Restriction Endonucleases, 104
`Other Enzymes Used in Molecular Cloning, 107
`Escherichia coli DNA Polymerase I, 108
`Klenow Fragment of E. coH DNA Polymerase !, 113
`T4 DNA Polymerase, 117
`Labeling the 5' Ends of DNA with T4 Polynucleotide Kinase, 122
`RNA*dependent DNA Polymerase, 128
`'
`Dephosphorylation of DNA, 133
`Nuclease 6a/3l, 135
`Nuclease Si, 140
`Mung-bean Nuclease, 141
`■Ribonucleases, 141
`Deoxribonuclease I, 142
`Exonuclease VII, 142
`Exonuclease III, 143
`X Exonuclease, 144
`Poly(A) Polymerase, 145
`T4 DNA Ligase, 146
`■
`T4 RNA Ligase, 147
`fcoRl Methylase, 147
`Terminal Deoxynucleotidyl Transferase, 148
`
`.
`
`,
`
`5 Gel Electrophoresis
`Agarose Gel Electrophoresis, 150
`Cei Electrophoresis Tanks, 153
`■
`Buffers, 156
`■ Preparation of Agarose Gels, 157
`Staining DNA in Agarose Cels, 161
`Photography, 162
`Minigels, 163
`Recovery of DNA from Agarose Cels, 164
`Alkaline Agarose Gels, 171
`Polyacrylamide cel Electrophoresis, 173
`Preparation of Polyacrylamide Gels, 174
`isolation of DNA Fragments from Polyacrylamide Gels, 178
`Strand-separating Gels, 179
`Strand Separation on Polyacrylamide Gels, 180
`Strand Separation on Agarose Gels, 182
`
`Merck Ex. 1095, Pg. 6
`
`

`

`CONTENTS vn
`
`187
`
`211
`
`Strand Separation of Short Duplex DNA by Electrophoresis through
`Denaturing Polyacrylamide Gels, 184
`
`6 Extraction, Purification, and Analysis of mRNA from
`Eukaryotic Cells
`Isolation of mRNA from Mammalian Ceils, 191
`Isolation of Total Cellular rna, 194
`Selection of Poly(A)'' RNA, 197
`Gel Electrophoresis of RNA, 199
`Nuclease-Si Mapping of RNA, 207
`
`7 Synthesis and Cloning of cDNA
`Synthesis of cDNA, 213
`Synthesis of the First cDNA Strand, 213
`Synthesis of the Second cDNA Strand, 214
`. Cleavage of the Hairpin Loop with Nuclease S1, 216
`Molecular Cloning of Double-stranded cDNA, 217
`Homopoiymeric Tailing, 217
`'
`Synthetic DNA Linkers, 219
`Other Methods of Cloning cDNA, 220
`Strategies for cdna Cloning, 224
`Abundant mRNAs, 224
`Low-abundance mRNAs, 225
`Procedures for cDIMA Cioning, 229
`Synthesis of Double-stranded cDNA, 230
`Digestion with Nuclease S1, 237
`Cioning Double-stranded cDNA, 239
`Annealing Vector and Double-stranded cDNA, 242
`Cloning Double-stranded cDNA by Sequential Addition of Linkers, 243
`
`,
`’
`
`8 Introduction of Plasmid and Bacteriophage k DNA into
`Escherichia coli
`Transformation of Escherichia coli by Plasmid DNA, 249
`Transformation by the Calcium Chloride Procedure, 250
`Transformation by the Calcium Chloride/Rubidium Chloride Procedure 252
`Transformation of £. coli xl776, 254
`'
`in Vitro Packaging of Bacteriophage \ DNA. 256
`Maintenance and Testing of Bacteriophage k Lysogens, 258
`Preparation of Extracts—Protocol l, 260
`'
`Packaging in Vitro—Protocol I, 262
`Preparation of Packaging Extracts—Protocol II, 264
`Packaging in Vitro—Protocol il, 268
`
`247
`
`9 Construction of Genomic Libraries
`Construction of Genomic libraries in Bacteriophage k Vectors, 270
`
`269
`
`Merck Ex. 1095, Pg. 7
`
`

`

`vlli CONTENTS
`
`Preparation of Vector DNA. 275
`Isolation of High-molecular-weight, Eukaryotic DNA from Cells Crown in
`Tissue Culture, 280
`Preparation of 20-kb Fragments of Eukaryotic DNA, 282
`Ligation and Packaging, 286
`Amplification of the Library, 293
`Construction of Genomic Libraries in cosmid vectors, 295
`Cloning in Phosphatase-treated Cosmid Vectors, 296
`Cloning in Cosmid Vectors Digested with Two Restriction Enzymes and
`Treated with Phosphatase, 300
`Amplification. Storage, and Screening of Cosmid Libraries, 304
`
`10 The Identification of Recombinant Clones
`309
`In Situ Hybridization of Bacterial Colonies or Bacteriophage Plaques, 312
`Screening Small Numbers of Bacterial Colonies, 313
`Replicating Colonies onto Nitrocellulose Filters, 316
`Screening Bacteriophage x Plaques by Hybridization, 320
`Screening by Hybridization Following In Situ Amplification of Bacteriophage
`k Plaques, 322
`Hybridization of DNA or RNA immobilized on Filters to Radioactive
`Probes, 324
`Hybridization to Nitrocellulose Filters Containing Replicas of Bacteriophage
`Plaques or Bacteria! Colonies, 326
`Identification of cDNA Clones by Hybridization Selection, 329
`Hybridization Selection Using DNA Bound to Nitrocellulose, 330
`Translation of Hybridization-selected RNA in Reticulocyte Lysates, 344
`Translation of Messenger RNA Injected into Frog Oocytes, 350
`, /
`Screening Bacteriophage k Libraries for Specific DNA sequences by >
`Recombination in E. coli, 353
`The Principle for Selection by Recombination, 353
`Strains Used in ttVX Screening, 356
`■
`.
`Preparation of ttVX, 356 ^
`_ ^
`Transformation of W3110 r m^ (p3), 357
`Plating Bacteriophage k Libraries on W3110 r m"^ (p3) (ttVX), 357
`Genetic Tests for Bacteriophage Containing a Suppressor Gene, 357
`Testing the ttVX System, 358.
`Using the ttVX System, 361
`
`11 Analysis of Recombinant DNA Clones
`Rapid Isolation of Plasmid or Bacteriophage k DNA, 365
`Rapid, Small-scale Isolation of Plasmid DNA, 366
`Rapid, Small-scale Isolation of Bacteriophage k DNA, 371
`Constructing Maps of Sites Cleaved by Restriction Endonucleases, 374
`Mapping by Single and Multiple Digestions, 376
`Sequential Digestion, 377
`Partial Digestion, 379
`
`■
`
`363
`
`Merck Ex. 1095, Pg. 8
`
`

`

`CONTENTS iX
`
`Southern Transfer. 382
`Transfer of DNA from Agarose Gels to Nitrocellulose Paper, 383
`Hybridization of Southern Filters, 387
`Subcloning small DNA Fragments into Plasmid Vectors, 390
`Subcloning DNA Fragments with Cohesive Ends, 591
`The Use of Synthetic DNA Linkers in Subcloning, 392
`Creating Restriction Sites by Ligation of Blunt-ended DNA Molecules, 398
`Carrying Out Sequential Cloning Steps Rapidly, 401
`
`403
`
`435
`
`12 vectors That Express Cloned DNA in Escherichia coli
`Promoters, 405
`Vectors Using the pl Promoter of Bacteriophage x, 406
`Other Promoters, 410
`Rfbosome-binding Sites, 411
`Expression of Eukaryotic Genes, 412
`vectors That Express Unfused Eukaryotic Proteins, 412
`. Vectors That Express Fused Eukaryotic Proteins, 422
`Maximizing Expression of Cloned Genes, 431
`Increased Gene Dosage, 432
`Summary, 433
`
`'
`
`Appendices
`Appendix A: Biochemical Techniques, 436
`Glassware and Plasticware, 437
`Preparation of Organic Reagents, 438
`Liquid Media, 440
`Solutions for Working with Bacteriophage k, 443
`Antibiotics, 444
`-
`Preparation of Buffers and Solutions, 445
`Proteolytic Enzymes, 450
`Enzymes, 451
`Buffers for Restriction of Endonuclease Digestion, 453
`Commonly Used Electrophoresis Buffers, 454
`Commonly Used Gel-loading Buffers, 455
`Preparation of Dialysis Tubing, 456
`.
`Drying Down ^^p-iabeled Nucleotides from Mixtures of Ethanol and
`Water, 457
`Purification of Nucleic Acids, 458
`Concentration of Nucleic Acids, 461
`Chromatography through Sephadex G-50, 464
`Quantitation of DNA and RNA, 468
`Autoradiography, 470
`Measurement of Radioactivity in Nucleic Acids, 473
`Preparation of Multimers of Plasmids as Molecular-weight Markers, 474
`Protocol for Sequencing by the Maxam-Cilbert Technique, 475
`
`. ft
`
`''Jim
`M
`
`Merck Ex. 1095, Pg. 9
`
`

`

`X CONTENTS
`
`Appendix B: pBR322, 479
`Nucleotide Sequence of pBR322, 479
`Restriction Sites in pBR322, 488
`Restriction Fragments of pBR322 DNA, 493
`Appendix C: commonly used Bacterial Strains, 504
`
`References, 507
`
`Index, 521
`
`/
`
`Merck Ex. 1095, Pg. 10
`
`

`

`Extraction, Purification,
`and Anaiysis of mRNA
`from Eukaryotic Ceiis
`
`6
`
`y
`
`/
`
`ii
`
`M
`
`u
`
`i '
`
`I
`
`B,
`
`Merck Ex. 1095, Pg. 11
`
`

`

`t
`it
`
`'> \A
`
`\ P
`
`\
`
`‘■'M
`
`188 EXTRACTION. PURIFICATION. AND ANALYSIS OF mRNA FROM EUKARYOTIC CELLS
`
`A typical mammalian cell contains about 10“^ jugof RNA, 80-85% of which is
`ribosomal (chiefly, 28S, 18S, and 5S), whereas 10-15% is made up of a variety
`of low-molecular-weight species (transfer RNAs, small nuclear RNAs, etc.).
`All of these RNAs are of defined size and sequence and can be isolated in
`virtually pure form by gel electrophoresis, density gradient centrifugation,
`or ion-exchange chromatography. By contrast, mRNA, which makes up
`between 1% and 5% of the total cellular RNA, is heterogeneous both in size
`(from a couple of hundred bases to several kilobases in length) and sequence.
`However, virtually all mammalian mRNAs carry at their 3' ends a poly(A)
`tract that is generally long enough to allow mRNAs to be purified by affinity
`chromatography on oligo(dT) cellulose. The resulting, physically heterogene­
`ous population of molecules collectively encodes all of the polypeptides syn­
`thesized by the cell.
`The keys to obtaining good preparations of eukaryotic mRNA are to min­
`imize ribonuclease activity during the initial stages of extraction and to
`avoid the accidental introduction of trace amounts of ribonuclease from the
`glassware and solutions. The following four elements are therefore impor­
`tant in the successful isolation of mRNA from mammalian cells.
`
`1. Use of Exogenous inhibitors of RNases
`Two types of inhibitors of RNase are currently in widespread use: vanadyl-
`ribonucleoside complexes and RNasin.
`
`Vanadyl-^ibonucleoside complexes. The complexes formed between tho^'
`oxovanadium ion and any of the four ribonucleosides are transition-st£d;e
`analogs that bind to many RNases and inhibit their activity almost com­
`pletely (Berger and Birkenmeier 1979). The four vanadyl-ribonucleoside
`complexes are added to intact cells and used at a concentration of 10 mM
`during all stages of RNA extraction and purification. The resulting mRNA
`is isolated in high yield and in a form that can be translated efficiently in
`cell-free, protein-synthesizing systems. If necessary, the vanadyl-ribonucleo-
`side complexes can be removed from the RNA preparation by multiple
`extractions with phenol containing 0.1% 8-hydroxyquinoline.
`Vanadyl-ribonucleoside complexes are prepared as follows (Berger and
`Birkenmeier 1979):
`
`1. Dissolve 0.5 mmole of each of the four ribonucleosides in 8 ml of water in a
`boiling-water bath.
`
`2. Purge the solution with nitrogen gas, while adding 1 ml of 2 M vanadyl
`sulfate.
`
`3. Adjust the pH to
`
`6 by dropwise addition of 10 M NaOH.
`
`Merck Ex. 1095, Pg. 12
`
`

`

`ISOLATION OFmRNA FROM MAMMALIAN CELLS 189
`
`4. Adjust the pH carefully to 7.0 by dropwise addition of 1 M NaOH under
`nitrogen gas in the water bath. As the complexes form, the solution
`changes color from blue to green-black.
`
`5. Adjust the volume to 10 ml; divide the solution into small aliquots and
`store at -20°C under nitrogen gas. The concentration of the complex is
`200 mM. Dilute 1:20 for use.
`
`Vanadyl-ribonucleoside complexes are commercially available from Bethes-
`da Research Laboratories, P.O. Box 577, Gaithersburg, MD 20760,
`
`RNasin. RNasin is a protein (Mr —40,000), isolated from rat liver and
`human placenta, that is a potent inhibitor of RNase. RNasin is effective
`during cell-free translation (Scheel and Blackburn 1979) and reverse tran­
`scription of mRNA (de Martynoff et al. 1980). Like vanadyl-ribonucleoside
`complexes, RNasin can be included in enzymatic reactions. Its advantage
`over vanadyl-ribonucleoside complexes is that it can be easily extracted with
`phenol.
`RNasin is commercially available from Biotec, Inc., 2800 Fish Hatchery
`Rd., Madison, WI 53711.
`
`2. Methods That Disrupt Cells and inactivate Nucleases Simultaneously
`Proteins readily dissolve in solutions of potent chaotropic agents such as
`guanidinium chloride and guanidinium isothiocyanate (Cox 1968). Cellular
`structures disintegrate and nucleoproteins dissociate rapidly from nucleic
`acids as ordered secondary structure is lost. Even RNase, an enzyme that is
`resistant to many forms of physical abuse (such as boiling), is inactive in the
`presence of 4 M guanidinium isothiocyanate and reducing agents like
`/3-mercaptoethanol (Sela et al. 1957). This combination of reagents can there­
`fore be used to isolate intact RNA from tissues, such as the pancreas, that are
`rich in RNase (Chirgwin et al. 1979).
`■
`Guanidinium isothiocyanate is made up according to the following steps.
`
`1. To a 100-g bottle of guanidinium isothiocyanate (Eastman Laboratory and
`Specialty Chemicals or Fluka), add 100 ml of deionized H2O, 10.6 ml of
`1 M Tris ■ Cl (pH 7.6), and 10.6 ml of 0.2 M EDTA. Stir overnight at room
`temperature.
`
`2. Warm the solution while stirring to 60-70°C for 10 minutes to assist
`dissolution. Often there is a residue of insoluble material that is removed
`by centrifugation at 3000p for 10 minutes at 20°C.
`
`3. Add 21.2 ml of 20% Sarkosyl (sodium lauryl sarkosinate) and 2.1 ml of
`^-mercaptoethanol to the supernatant and bring the volume to 212 ml
`with sterile H2O.
`
`Merck Ex. 1095, Pg. 13
`
`

`

`190 EXTRACTION, PURIFICATION, AND ANALYSIS OF mRNA FROM EUKARYOTIC CELLS
`
`4. Filter through a disposable Nalgene filter and store at 4°C in a tightly
`sealed, brown glass bottle.
`.
`
`3. Use of RNase-free Glassware and Plasticware
`Sterile, disposable plasticware is essentially free of RNase and can be used
`for the preparation and storage of RNA without pretreatment. General
`laboratory glassware, however, is often a source of RNase contamination and
`should be treated by baking at 250°C for 4 or more hours. In addition, some
`workers treat glassware for 12 hours at 37®C with a solution of 0.1% diethyl-
`pyrocarbonate, which is a strong but not absolute inhibitor of RNase
`(Fedorcsak and Ehrenberg 1966). Before using glassware treated in this
`way, it is important to remove traces of diethylpyrocarbonate by heating to
`lOO^C for 15 minutes (Kumar and Lindberg 1972) or by autoclaving. Other­
`wise, there is a danger that the remaining traces of diethylpyrocarbonate
`will inactivate the RNA by carboxymethylation.
`'
`It is a good idea to set aside items of glassware and batches of plasticware
`that are to be used only for experiments with RNA, to mark them distinc­
`tively, and to store them in a designated place.
`A potentially major source of contamination with RNase is the hands of
`investigators. There is little use in going to great lengths to rid glassware of
`contamination if no care is taken to keep one’s fingers out of harm’s way.
`Gloves should therefore be worn at all stages during the preparation of
`materials and solutions used for the isolation and analysis of RNA and dur­
`ing all manipulations involving RNA.
`
`4. Careful Preparation of Solutions
`All solutions should be prepared using baked glassware, glass-distilled au6»-
`claved water, and dry chemicals that are reserved for work with RNA and
`that are handled with baked spatulas. Wherever possible, the solutions
`should be treated with 0.1% diethylpyrocarbonate for at least 12 hours and
`autoclaved (15 minutes, liquid cycle). Note that diethylpyrocarbonate cannot
`be used to treat solutions containing Tris. It is highly unstable in the pres­
`ence of Tris buffers and decomposes rapidly into ethanol and carbon dioxide.
`
`Merck Ex. 1095, Pg. 14
`
`

`

`ISOLATION OFmRNA FROM MAMMALIAN CELLS 191
`
`/
`
`ISOLATION OF mRNA FROM MAMMALIAN CELLS
`The method given below is a modification of that of Favaloro et al. (1980) for
`the isolation of mRNA from monolayers of mammalian cells grown in tissue
`culture. However, it can also be used to isolate mRNA from mammalian cells
`grown in suspension or from any mammalian tissue that can be dispersed
`into single cells.
`
`1. Remove the medium from the cells and wash the monolayers three or
`four times with ice-cold, phosphate-buffered saline (PBS). Add 2 ml of
`ice-cold PBS to each of the plates and stand them on a bed of ice.
`
`2. Scrape off the cell sheet from each plate in turn by using a rubber
`policeman. With a wide-mouthed pipette, transfer the cell suspension
`into a Corex centrifuge tube and store on ice until the cells have been
`removed from all of the plates.
`
`3. Centrifuge at 2000fir for 5 minutes at 4°C,
`
`/
`
`4. Remove the supernatant by aspiration and resuspend the cell pellet in
`ice-cold lysis buffer (0.25 ml per 85-mm dish).
`
`Lysis buffer
`0.14 M NaCl
`1.5 mM MgCh
`10 mM Tris • Cl (pH 8.6)
`0.5% NP-40
`1000 units/ml RNasin
`10 mM vanadyl-ribonucleoside complexes
`or
`
`•
`
`.
`
`5. Vortex for 10 seconds and then underlay the cell suspension with an
`equal volume of lysis buffer containing sucrose (24% w/v) and NP-40 (1%).
`Store on ice for 5 minutes.
`
`6. Centrifuge at 10,000p for 20 minutes at 4°C in a swing-out rotor.
`
`7. Recover the turbid, upper (cytoplasmic) layer and add an equal volume
`of 2 X PK buffer.
`
`2 X PK buffer
`0.2 M Tris-Cl (pH 7.5)
`25 mM EDTA
`0.3 M NaCl
`2% w/v SDS
`Add proteinase K to a final concentration of 200 iiglml. Mix and incu­
`bate at 37°C for 30 minutes.
`
`Merck Ex. 1095, Pg. 15
`
`

`

`192 EXTRACTION, PURIFICATION, AND ANALYSIS OF mRNA FROM EUKARYOTIC CELLS
`
`Note, If nuclear RNA is also to be prepared, discard the clear sucrose
`phase and resuspend the nuclear pellet at the bottom of the centrifuge
`tube in lysis buffer (0.25 ml per 85-mm dish). Add an equal volume of 2 x
`PK buffer and proteinase K to a final concentration of 200 ixg/ml. Dis­
`rupt the nuclei and shear the liberated DNA by repeatedly squirting the
`viscous solution through a sterile 19-gauge hypodermic needle. Incubate
`at 37°C for 30 minutes.
`
`8. Remove the proteins by extracting once with phenol/chioroform.
`
`9. Recover the aqueous phase, add 2.5 volumes of ethanol, and store at
`-20°C for at least 2 hours.
`
`10. Centrifuge for 10 minutes at 5000^' at 0°C. Discard the supernatant and
`wash the pellet with 75% ethanol containing 0.1 M sodium acetate (pH
`5.2).
`
`11. Redissolve nucleic acids in a small volume (50 m1 per 85-mm dish) of:
`50 mM Tris • Cl (pH 7.5)
`1 mM EDTA
`
`Then add MgCh to 10 mM and RNasin or vanadyl-ribonucleoside com­
`plexes to final concentrations of 2000 units/ml or 2 mM, respectively.
`• Add pancreatic DNase I (Worthington RNase-free DPFF) from which
`RNase has been removed either by chromatography on agarose-5'-(4-
`aminophenyl-phosphoryl) uridine 2'(3') phosphate (Miles) as described
`by Maxwell et ai. (1977) (see page 451) or by adsorption to macaloid
`(Schaffner 1982) (see page 452). Incubate for 30 minutes at 37°C. '
`12. Add EDTA and SDS to final concentrations of 10 mM and 0.2%,
`respectively.
`
`13. Extract the solution once with phenol/chloroform.
`
`14. Add sodium acetate (pH 5.2) to 0.3 M and precipitate the nucleic acids
`with 2 volumes of ethanol. Store the RNA in 70% ethanol at -70°C.
`Cytoplasmic RNA may be further purified and freed from any con­
`taminating oligodeoxyribonucleotides by chromatography on oligo(dT)-
`cellulose (see page 197).
`
`Note
`i. Oligodeoxyribonucleotides contaminating preparations of nuclear RNA
`may be removed as follows:
`
`Merck Ex. 1095, Pg. 16
`
`

`

`ISOUTION OF mRNA FROM MAMMALIAN CELLS 193
`
`a. Resuspend the pellet in 20% sodium acetate by repeated pipetting up
`and down.
`
`b. Centrifuge for 10 minutes in an Eppendorf centrifuge.
`
`c. Discard the supernatant and redissolve the pellet in TE. Precipitate
`with ethanol.
`
`ii. Cytoplasmic RNA can usually be purified by oligo(dT) chromatography
`without DNase treatment.
`
`M-I
`
`Merck Ex. 1095, Pg. 17
`
`

`

`194 EXTRACTION, PURIFICATION. AND ANALYSIS OF mRNA FROM EUKARYOTIC CELLS
`
`ISOLATION OF TOTAL CELLULAR RNA
`
`The two methods given below are used to isolate RNA from cells that cannot
`be fractionated easily into cytoplasm and nuclei (e.g., frozen fragments of
`tissue) or from cells that are particularly rich in RNase (e.g., pancreatic
`cells).
`
`Guanidinium/Hot Phenol Method^
`1. Add 4 M guanidinium isothiocyanate mixture (prepared as described on
`page 189) to a tissue fragment or washed cell pellet in a plastic, disposa­
`ble centrifuge tube. Use 1 ml of guanidinium isothiocyanate mixture for
`10’ cells or 5 ml for every gram of tissue.
`Note. Tissue fragments may require disruption by homogenization in an
`omnimixer or polytron mixer.
`,
`
`2. Bring the mixture to 60°C and, while maintaining this temperature,
`draw the slimy suspension into a syringe fitted with an 18-gauge needle.
`Forcefully eject the suspension back into the tube. Repeat until the vis­
`cosity of the suspension is reduced by shearing of the liberated chromo­
`somal DNA.
`
`3. Add an equal volume of phenol preheated to 60°C and continue to pass
`the emulsion through the syringe.
`
`4. Add 0.5 volume of:
`
`0.1 M sodium acetate (pH 5.2)
`10 mM Tris Cl (pH 7.4)
`1 mM EDTA
`
`5. Add an equal volume of a 24:1 solution of chloroform and isoamyl alcohol
`and shake vigorously for 10-15 minutes while maintaining the tempera­
`ture at 60°C.
`
`6. Cool on ice and centrifuge at 20009^ for 10 minutes at 4°C.
`
`7. Recover the aqueous phase and reextract with phenol/chloroform.
`
`8. Centrifuge and recover the aqueous phase and reextract twice with
`chloroform.
`
`9. Add 2 volumes of ethanol. Store at -20°C for 1-2 hours.
`
`10. Recover the RNA by centrifugation at 12,000gf for 20 minutes at 4°C.
`'Feramisco et al. (1982)
`
`Merck Ex. 1095, Pg. 18
`
`

`

`ISOLATION OF TOTAL CELLULAR RNA 195
`
`11. Dissolve the pellet in the original starting volume (step 1) of:
`
`0.1 M Tris-Cl (pH 7.4)
`50 mM NaCi
`10 mM EDTA
`0.2% SDS
`Add proteinase K to a final concentration of 200 M^/ml. Incubate for 1-2
`hours at 37°C.
`12. Heat to 60°C. Add 0.5 volume of phenol preheated to 60°C and mix. Add
`0.5 volume of chloroform and mix vigorously at 60°C for 10 minutes.
`
`13. Cool in ice and centrifuge at 2000gr for 10 minutes at 4°C.
`
`14. Extract once more with phenol/chloroform at 60°C and then extract
`twice with chloroform at room temperature.
`15. Precipitate the nucleic acids with ethanol by centrifugation and rinse
`the pellet in 70% ethanol. Store the RNA in 70% ethanol at -70°C.
`
`16. Dissolve the RNA in sterile water. 5 x 10^ cells should yield approxi­
`mately 5-10 mg of RNA.
`
`/
`
`a
`
`n
`
`m
`
`Merck Ex. 1095, Pg. 19
`
`

`

`196 EXTRACTION, PURIFICATION, AND ANALYSIS OF mRNA FROM EUKARYOTIC CELLS
`
`Guanldinium/Ceslum Chloride Method^
`1. To a fragment of tissue or a cell pellet, add 5 volumes of:
`6 M guanidinium isothiocyanate
`5 mM sodium citrate (pH 7.0)
`0.1 M ^-mercaptoethanol
`0.5% Sarkosyl
`
`.
`
`Disperse the tissue by homogenization or the cell pellet by vortexing.
`
`2. Add 1 g of cesium chloride to each 2.5 ml of homogenate.
`
`3. Layer the homogenate onto a 1.2-ml cushion of 5.7 M CsCl in 0.1 M EDTA
`(pH 7.5) in a Beckman SW50.1 polyallomer tube (or its equivalent). (Other
`types of centrifuge tubes can be used; see Chirgwin et al. [1979]).
`
`4. Centrifuge at 35,000 rpm for 12 hours at 20°C. This procedure takes
`advantage of the fact that the buoyant density of RNA in cesium chloride
`is much greater than that of other cellular macromolecules. During ..
`cen-
`trifugation, the RNA forms a pellet on the bottom of the tube while most
`of the DNA and protein floats upward in the cesium chloride solution.
`
`5. Discard the supernatant, dry the walls of the centrifuge tubes thoroughly,
`and dissolve the pellet of RNA in:
`
`10 mM Tris-Cl (pH 7.4)
`5 mM EDTA
`1% SDS
`
`6. Extract once with a 4:1 mixture of chloroform and 1-butanol and transfer
`the aqueous phase to a fresh tube. Reextract the organic phase with an
`equal volume of:
`
`10 mM Tris • Cl (pH 7.4)
`5 mM EDTA
`1% SDS
`
`Combine the two aqueous phases.
`
`.
`
`7. Add 0.1 volume of 3 M sodium acetate (pH 5.2) and 2.2 volumes of ethanol.
`Store at — 20°C for at least 2 hours. Recover the RNA by centrifugation.
`
`8. Dissolve the pellet in 1 ml of H2O and reprecipitate with ethanol. Store the
`RNA in 70% ethanol at ~70°C.
`
`'Glisin et al. (1974); Ullrich et al. (1977).
`
`Merck Ex. 1095,

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket